Acquisition Advantage The recent acquisition by Bora Pharmaceuticals indicates potential expanded distribution channels and increased resources, creating opportunities for collaboration and expanding market reach within the pharmaceutical industry.
Specialized Focus Pyros Pharmaceuticals' emphasis on rare pediatric diseases and underserved populations positions it well to partner with healthcare providers, payers, and specialty pharmacies seeking targeted treatment options.
Partnership Opportunities Recent strategic partnerships, such as with AnovoRx for patient support, highlight the company's commitment to patient-centric solutions, offering avenues for joint initiatives and value-added services.
Growth Potential With revenues between 10 to 25 million dollars and a focused small team, there is significant room for growth through strategic alliances, new therapeutic development, and expanded outreach efforts.
Market Positioning Operating in a niche with technically challenging drug delivery mechanisms, Pyros can appeal to specialty pharmaceutical stakeholders interested in innovative solutions for complex treatments.
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10BPyros Pharmaceuticals uses 8 technology products and services including Microsoft Clarity, Cloudflare CDN, Google Hosted Libraries, and more. Explore Pyros Pharmaceuticals's tech stack below.
| Pyros Pharmaceuticals Email Formats | Percentage |
| First@pyrospharma.com | 45% |
| FLast@pyrospharma.com | 8% |
| FirLast@pyrospharma.com | 2% |
| First@pyrospharma.com | 45% |
Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees
Pyros Pharmaceuticals is a specialty pharmaceutical company focused on developing medicines for rare pediatric diseases and underserved patient populations. We explore a broad range of therapeutic areas that have technically challenging drug delivery mechanisms or other niche applications. Our goal is to provide high-quality, affordable and accessible alternatives for patients that need them the most.
Company Overview
Funding & FinancialsPyros Pharmaceuticals has raised a total of $450K of funding over 2 rounds. Their latest funding round was raised on Apr 04, 2022 in the amount of $450K.
Pyros Pharmaceuticals's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsPyros Pharmaceuticals has raised a total of $450K of funding over 2 rounds. Their latest funding round was raised on Apr 04, 2022 in the amount of $450K.
Pyros Pharmaceuticals's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com